Composition for preventing or treating inflammation
    1.
    发明授权
    Composition for preventing or treating inflammation 有权
    用于预防或治疗炎症的组合物

    公开(公告)号:US08575089B2

    公开(公告)日:2013-11-05

    申请号:US13390888

    申请日:2010-08-17

    IPC分类号: A61K38/00 A61P5/00

    CPC分类号: A61K38/08

    摘要: The present invention relates to a composition containing Substance P for preventing or treating an inflammation. The composition containing Substance P according to the present invention exhibits the effect of decreasing leukocytes, neutrophils and hematopoietic stem cells in a blood, which are associated with the inflammation, and of increasing anti-inflammatory cytokines, regulatory T-lymphocytes, anti-inflammatory macrophages and the like, thereby terminating inflammatory response at an early stage, and is thus highly effective in preventing and treating the inflammation caused by a non-traumatic, traumatic, infectious or ischemic retinal injury.

    摘要翻译: 本发明涉及含有用于预防或治疗炎症的物质P的组合物。 含有根据本发明的物质P的组合物具有降低血液中与炎症相关的白细胞,嗜中性粒细胞和造血干细胞以及增加抗炎细胞因子,调节性T淋巴细胞,抗炎巨噬细胞的作用 从而在早期终止炎症反应,因此在预防和治疗由非创伤性,创伤性,感染性或缺血性视网膜损伤引起的炎症方面非常有效。

    KIT FOR DIAGNOSING PROSTATE CANCER AND DIAGNOSIS METHOD
    4.
    发明申请
    KIT FOR DIAGNOSING PROSTATE CANCER AND DIAGNOSIS METHOD 审中-公开
    用于诊断前列腺癌和诊断方法的工具箱

    公开(公告)号:US20120252040A1

    公开(公告)日:2012-10-04

    申请号:US13516460

    申请日:2010-11-29

    IPC分类号: G01N33/574 C07K16/40

    CPC分类号: G01N33/57434

    摘要: The present invention relates to a kit and method for diagnosing prostate cancer, which use an antibody to prostate-specific antigen (PSA) to detect PSA in human urine. More specifically, the invention relates to a kit for diagnosing prostate cancer, which comprises an antibody to PSA and uses human urine as a sample, and to a method for diagnosing prostate cancer, which comprises brining a human urine sample into contact with an antibody to PSA in order to detect PSA in the sample.

    摘要翻译: 本发明涉及一种用于诊断前列腺癌的试剂盒和方法,其使用前列腺特异性抗原(PSA)的抗体来检测人尿中的PSA。 更具体地,本发明涉及用于诊断前列腺癌的试剂盒,其包含PSA的抗体并使用人尿作为样品,以及用于诊断前列腺癌的方法,其包括使人尿样品与抗体接触 PSA以检测样品中的PSA。

    AGENT FOR STIMULATING MOBILIZATION OF ENDOTHELIAL PROGENITOR CELLS
    6.
    发明申请
    AGENT FOR STIMULATING MOBILIZATION OF ENDOTHELIAL PROGENITOR CELLS 审中-公开
    刺激内源性原核细胞动员的药剂

    公开(公告)号:US20120142596A1

    公开(公告)日:2012-06-07

    申请号:US13389954

    申请日:2010-08-12

    CPC分类号: A61K38/046

    摘要: The present invention provides a composition for stimulating the mobilization of endothelial precursor cells, which comprises substance-P (SP). Substance-P according to the invention exhibits an activity of stimulating the mobilization of endothelial precursor cells from the bone marrow, thereby stimulating vasculogenesis. Thus, substance-P exhibits excellent effects on the prevention or treatment of diseases, including myocardial infarction, angina, ischemic stroke, cerebrovascular dementia, cerebral infarction, sequelae of cerebral injury, spinal cord injury, sequelae of spinal nerve injury, degenerative diseases, sequelae of cerebral infarction, peripheral nerve disorders, presbyopia, degenerative hearing loss, sequelae of brain surgery, and diabetic ulcer, which are accompanied by ischemic vascular injury or traumatic vascular injury.

    摘要翻译: 本发明提供了一种用于刺激内皮前体细胞动员的组合物,其包括物质-P(SP)。 根据本发明的物质-P表现出刺激内皮前体细胞从骨髓的动员,从而刺激血管发生的活性。 因此,物质-P对预防或治疗包括心肌梗死,心绞痛,缺血性中风,脑血管性痴呆,脑梗塞,脑损伤后遗症,脊髓损伤,脊髓神经损伤后遗症,退行性疾病,后遗症等疾病的预防或治疗具有优异的效果 的脑梗塞,周围神经障碍,老花眼,退行性听力损失,脑外科后遗症和糖尿病性溃疡,伴有缺血性血管损伤或创伤性血管损伤。